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Abstract
Aim: There are substantial differences in the amount of research concerned with different disorders. This paper considers why.
Methods: Bibliographic searches were conducted to identify publications (1985–2009) concerned with 35 neurodevelop-
mental disorders: Developmental dyslexia, Developmental dyscalculia, Developmental coordination disorder, Speech sound
disorder, Specific language impairment, Attention deficit hyperactivity disorder, Autistic spectrum disorder, Tourette
syndrome, Intellectual disability, Angelman syndrome, Cerebral palsy, Cornelia de Lange syndrome, Cri du chat syndrome,
Down syndrome, Duchenne muscular dystrophy, Fetal alcohol syndrome, Fragile X syndrome, Galactosaemia, Klinefelter
syndrome, Lesch-Nyhan syndrome, Lowe syndrome, Marfan syndrome, Neurofibromatosis type 1, Noonan syndrome,
Phenylketonuria, Prader-Willi syndrome, Rett syndrome, Rubinstein-Taybi syndrome, Trisomy 18, Tuberous sclerosis, Turner
syndrome, Velocardiofacial syndrome, Williams syndrome, XXX and XYY. A publication index reflecting N publications
relative to prevalence was derived.
Results: The publication index was higher for rare than common conditions. However, this was partly explained by the
tendency for rare disorders to be more severe.
Interpretation: Although research activity is predictable from severity and prevalence, there are exceptions. Low rates of
research, and relatively lowlevelsof NIH funding, characteriseconditionsthatarethe domainof a singlediscipline withlimited
research resources. Growth in research is not explained by severity, and was exceptionally steep for autism and ADHD.
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Introduction
It is well recognised that there are substantial differences in the
amount of research activity concerned with different medical
conditions, but the reasons for disparities are not fully understood.
Within the field of neurology, Al-Shahi and colleagues found that
the amount of research into a condition was not proportionate to
the frequency of the disease [1]. Common conditions such as
stroke or migraine were under-researched relative to rare diseases
such as Wilson’s disease or Creutzfeldt-Jakob disease, when
assessed using ‘publication ratio’, a measure of number of
publications divided by disease frequency. They suggested that
as well as political, economic and scientific interest, research
activity might also be influenced by the fashionable nature of some
conditions, and recommended that similar analyses should be
conducted in other areas. However, their analysis did not take into
account the severity of disease, which might be expected to play
some part in research priorities. A review of grants awarded by the
National Institutes of Health [2] confirmed that research funding
was not related to how common a disease was, but it was related to
disease burden, as indicated by mortality, years of life lost, and
disability-adjusted life years. Thus severity of the impact of a
condition seemed to play a larger role in determining research
priorities than disease frequency.
The field of neurodevelopmental disorders is a microcosm in
which these issues can be further explored. The term neurodevel-
opmental disorder is used in two ways [3]. The first refers to
conditions affecting children’s neurological development with a
known genetic or acquired etiology, such as Fragile X syndrome
or fetal alcohol syndrome. The second use refers to conditions
of presumed multifactorial etiology in which certain aspects of
neurodevelopment are selectively impaired; this includes such con-
ditions as autistic disorder, developmental dyslexia, and attention-
deficit hyperactivity disorder (ADHD). Both types of condition
were included in the current analysis. In this article, counts are
provided for publications in this field to consider how far the
amount of a research on a condition can be explained by (a)
frequency of disorder, (b) severity of disorder or (c) the disciplines
involved in research. In addition, research activity is evaluated in
terms of funding by the National Institutes of Health (NIH)
relating to these conditions.
Methods
Conditions included in the analysis
The conditions included in this review are shown in Table 1.
These were identified from Rutter’s Textbook of Child and
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phenotypes [5]. Those from the latter source were included only if
an estimate of prevalence was available. The category of
‘intellectual disability’ (ID) posed problems, because this can be
both a symptom of a known disorder, and a nonsyndromal
condition of unknown etiology. Furthermore, in the UK, the term
‘learning disability’ is used to refer to intellectual disability,
whereas elsewhere ‘learning disability’ is used for specific
difficulties in a child of normal IQ. Despite these problems, it
was decided to attempt an estimate of publications focusing on ID,
but data on this condition need to be treated with particular
caution.
Table 1. Search terms (in title) used to identify neurodevelopmental disorders.
Presumed multifactorial etiology Known etiology
‘‘Developmental dyslex*’’ ‘‘Angelman syndrome’’
OR dyslex* NOT (acquired OR deep OR surface) ‘‘Cerebal pals*’’
OR ‘‘specific reading disab*/retard*/impair*/difficulties’’ ‘‘Cornelia de Lange syndrome’’
OR ‘‘developmental reading disorder*’’ OR ‘‘Brachmann-de Lange’’
‘‘Developmental dyscalcul*’’ ‘‘Cri du chat syndrome’’
OR ‘‘specific arithmetic*/math* disab*/retard*/disorder*’’ OR ‘‘deletion 5p’’
NOT dyscalcul* Down syndrome1
‘‘Developmental coordination disorder**’’ ‘‘trisomy 21’’
OR ‘‘developmental co-ordination disorder*’’ ‘‘Duchenne muscular dystrophy’’
OR "developmental dysprax* ‘‘Fetal alcohol syndrome’’
OR ‘‘clumsy child*’’ NOT dysprax* ‘‘foetal alcohol syndrome’’
‘‘Speech sound disorder*’’ ‘‘Fragile X syndrome’’ OR FraX
OR ‘‘articulation difficulties’’ AND child* NOT palate Galactosemia OR Galactosaemia
OR ‘‘articulation disorder*’’ AND child* ‘‘Klinefelter* syndrome’’ OR XXY
OR ‘‘apraxia of speech’’ AND (childhood OR developmental) ‘‘Lesch-Nyhan syndrome’’
OR (‘‘delayed speech’’ OR ‘‘speech delay’’) NOT palate ‘‘Lesch Nyhan syndrome’’
OR ‘‘developmental apraxia of speech’’ ‘‘Lowe/Lowe’s syndrome’’
OR ‘‘developmental articulation/phonological disab*/disorder*’’ ‘‘Marfan syndrome’’
OR ‘‘developmental phonological impair*/problem*’’ ‘‘Neurofibromatosis type 1’’
OR ‘‘developmental verbal dyspraxia’’ ‘‘Neurofibromatosis type I’’
OR ‘‘phonological disabi*/disorder*/impair*problems’’ AND child* NOT developmental ‘‘Noonan syndrome’’
OR ‘‘speech difficulties/disorder*/impair*’’ AND child* Phenylketonuria OR PKU
OR ‘‘phonological disabi*/disorder*/impair*problems’’ AND child* NOT developmental ‘‘Prader-Willi syndrome’’
OR ‘‘speech difficulties/disorder*/impair*’’ AND child* ‘‘Rett/Rett’s syndrome’’
‘‘Specific language impair*’’ ‘‘Rubinstein-Taybi syndrome’’
OR ‘‘developmental dysphas*/aphas*’’ ‘‘Smith-Magenis syndrome’’
OR ‘‘developmental language’’ AND ‘‘Trisomy 18’’
disorder*/impair*disab*/difficult* OR ‘‘Edwards syndrome’’
OR SLI NOT specific impairment potato* gene elegans battery ‘‘Tuberous sclerosis’’
flight arithmetic SLI-1 crystal BMT laser somatostatin gastrin ‘‘Turner* syndrome’’ NOT Ullrich
OR ‘‘language learning disab*’’ ‘‘Velocardiofacial syndrome’’
‘‘Attention deficit hyperactivity disorder*’’ OR ‘‘Velo-cardio-facial syndrome’’
OR ‘‘attention deficit’’ NOT (hyperactiv* OR schiz*) OR ‘‘22q11.2 deletion’’
OR ADHD NOT ‘‘attention deficit’’ ‘‘Williams syndrome’’
Autism OR autistic OR ‘‘Williams-Beuren syndrome’’
OR (Asperger OR PDDNOS OR ‘‘pervasive developmental OR ‘‘idiopathic infantile
disorder’’) NOT autis* hypercalcaemia/calcemia’’
‘‘Tourette* syndrome’’ XXX AND (female* OR karyotype
‘‘Intellectual disability/handicap/retardation’’ OR chromosome OR trisomy)
OR ‘‘mental handicap/retardation’’ XYY
OR ‘‘learning disab*’’ NOT specific
Term in bold is main category; plain text beneath indicates alternative search terms. Asterisk is wildcard symbol.
1 Estimated from rate for ‘trisomy 21’: see text.
doi:10.1371/journal.pone.0015112.t001
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Estimates of prevalence per 100 were computed from Rutter et al.
[4] or Udwin and Dennis [5], with the mean being used if a range
was given.
Severity of condition
Measures of disease burden used in mainstream medicine focus
mainly on mortality and morbidity and are not in general
appropriate for neurodevelopmental disorders. It was therefore
necessary to derive an ad hoc measure for this study. This was a 4-
point scale representing the extent to which an affected individual
could be expected to obtain educational qualifications and live
independently in adulthood (see Table 2). Nine expert clinicians
who saw children with neurodevelopmental disorders were asked
to estimate severity for conditions shown in Table 1 on this scale.
For some conditions, this scale was difficult to apply because of the
wide variation in severity. For instance, a person with autistic
disorder is unlikely to fall in category 1, but could fall into category
2, 3 or 4. In such a case, raters were asked to give their best
estimate of the average level of severity. The data in Table 3 shows
the average across all raters. For rare conditions, few clinicians had
sufficient experience of cases to be able to make a judgement, and
in those cases, the author provided a rating based on the
description of the phenotype in Udwin and Dennis [5].
Estimates of number of publications
Web of Knowledge was the basis for research counts; the search
terms used are shown in Table 1; for a paper to be counted, the search
term had to appear in the title. This exercise revealed that some
disorders lacked consistent terminology and were correspondingly
hard to search. Total number of articles for each condition was
obtained for 5-year bands from 1985 to 2009. Note that coding of
articles was not mutually exclusive, so that if search terms for two
conditions were included in the title, the same article would be
counted towards toward the total for both conditions. The word
‘Down’ is not a valid search term in Web of Knowledge, so it was
necessary to estimate the number of articles on Down syndrome.
From a Google scholar search it was established that 9.9% of articles
on Down syndrome include ‘trisomy 21’ in the title. Thus the number
of articles on Down syndrome in Web of Knowledge was estimated by
multiplying the number of articles with ‘trisomy 21’ in the title by 10.1.
Publication index
This was derived in a method similar to that used by Al-Shahi
et al [1] by dividing the total number of articles by prevalence. This
was scaled so that it could be readily interpreted as a count of the N
papers in 25 years per 100 affected cases in a population of 11.56
million, which is an estimate of number of children in the UK [6].
Rate of increase in publications
This measure was derived by computing the slope of the line
linking the number of publications in 5-year time bins across the
period 1985–2009.
Estimates of amount of genetic/animal research
Preliminary analyses suggested that the amount of research on a
condition was partly determined by the disciplines involved; for
some conditions, a high proportion of studies involved genetics
and/or mouse models. To gain an estimate of how much research
on each condition was of this type, searches were re-run to find the
proportion of papers on a condition that had the words ‘gene’,
‘genetic’, ‘mouse’, ‘mice’ or ‘chromosome’ in the topic field.
Amount of funding by the National Institutes of Health
(NIH)
Data on NIHfundingwere obtained usingthe Research Portfolio
Online Reporting Tools (RePORT) (http://projectreporter.nih.
gov/reporter.cfm). Foreachdisorder, the database wasinterrogated
to identify funded projects for the period 2000–2010, and the total
funding in thousands of dollars was computed, together with the
NIH institute that provided the funds. It is important to note that
the RePORT software identifies projects on the basis of keywords,
and may include projects that do not have a central focus on the
disorder in question. This means that, on the one hand, the amount
of funding focused on a specific disorder is likely to be over-
estimated, and on the other hand, that the same project is likely to
be included in counts for more than one disorder. For this analysis,
it proved impossible to obtain realistic estimates of funding for
studies of intellectual disability, as the search terms from Table 1
identified numerous projects concerned with a wide range of
disorders. This category was therefore omitted from this analysis.
For the remaining conditions, a measure of rate of increase in
funding between 2000–2010 was computed from the slope of the
function for funding by year.
Results
Table 3 shows the estimates of prevalence, severity of condition,
number of publications, rate of increase in publications, propor-
tion of genetic/animal papers for each condition, and publication
index, with disorders ranked by prevalence. Most variables were
skewed, and so nonparametric Spearman correlations were used
when assessing association between variables.
The first point to note is that the publications count has only
a weakly significant relationship to prevalence of a condition
(rs=.34, N=35, p=.046). To explore predictors of publications,
the publication index was used, i.e. a measure that reflects the
number of publications relative to estimated number of affected
individuals. It is evident on inspection that there is a general trend
for a higher publication index for the rarer conditions; the
Spearman correlation between publication index and prevalence is
rs=2.91, N=35, p,.001. However, when we consider the
common conditions, we see that most of them have a relatively low
severity index; indeed, there is a significant negative correlation
between severity and prevalence, rs=2.61, N=35, p,.001.
Furthermore, the severe, rare conditions are more likely than
common, milder conditions to be monogenic disorders, consistent
Table 2. Coding of severity of impact of condition.
1 Little impact on ability to obtain educational qualifications and live independently
2 Likely to have poorer than average educational qualifications but can live independently
3 Likely to require special schooling; may be employable in adulthood, but likely to need support in daily living
4 Likely to require full-time care and support during childhood and adulthood
doi:10.1371/journal.pone.0015112.t002
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publications including terms indicative of genetic studies; the
correlation between % genetic papers and prevalence was
rs=2.52, N=35, p=.001. The correlation between % genetic
papers and severity was also significant: rs=.41, N=35, p=.015.
Further analysis was conducted to consider how far the pub-
lication index for each condition related to severity and genetic
content. A regression analysis was conducted to find the best-fitting
function relating severity to publication index, and a log-log
relationship gave the best fit, with R=.648, p,.001. Figure 1 shows
the scatterplot relating mean log severity to log publication index,
together with the line showing predicted log publication index.
Adding the proportion of genetic papers as an independent
variable led to a significant increase of fit to give R=.728; change
in fit: F (1,32)=7.51 p=.01. Adding prevalence to the model after
including severity and genetic index, accounted for a further
24.3% of the variance, change in fit: F (1,31)=33.24, p,.001,
bring the multiple R up to .879.
Table 3. Prevalence per 100, severity rating, number of publications (1985–2009), rate of increase in publications, % publications
with genetic/animal model content, estimated N affected children in the UK, and publication index for each condition, ordered by
prevalence.
Condition
Prevalence
per 100
1
Mean
severity
N pubs
in 25 yr
Rate of
increase
2
%
genet.
N cases
in UK
Pub.
index
3
Lesch-Nyhan syndrome 0.0005 4.00 428 214 69 57 750.88
Lowe syndrome 0.0005 4.00 171 1 67 57 300.00
Rubinstein-Taybi syndrome 0.0008 3.50 291 2 48 92 316.30
Cornelia de Lange syndrome 0.0014 4.00 420 20 54 165 254.55
Cri du chat syndrome 0.0020 4.00 162 1 79 231 70.13
Galactosaemia 0.0020 2.50 678 8 46 231 293.51
Angelman syndrome 0.0040 3.79 690 36 80 462 149.35
Williams syndrome 0.0044 3.31 1,349 87 54 513 262.96
Marfan syndrome 0.0067 1.50 1,805 71 53 770 234.42
Prader-Willi syndrome 0.0067 3.17 1,851 82 58 770 240.39
Rett syndrome 0.0080 3.94 1,918 35 59 924 207.58
Phenylketonuria 0.0100 2.00 2,941 9 51 1,156 254.41
Duchenne muscular dystrophy 0.0143 2.50 3,212 228 64 1,651 194.55
Tuberous sclerosis 0.0167 2.69 3,083 76 42 1,926 160.07
Trisomy 18 0.0250 3.70 661 21 75 2,890 22.87
Velocardiofacial syndrome 0.0250 2.72 839 83 82 2,890 29.03
Neurofibromatosis type 1 0.0308 2.00 1,840 151 62 3,556 51.74
Turner syndrome 0.0400 1.94 2,485 21 60 4,624 53.74
XYY 0.0545 2.00 251 26 86 6,300 3.98
XXX 0.0550 1.50 62 23 87 6,358 0.98
Noonan syndrome 0.0571 2.50 635 44 67 6,605 9.61
Fragile X syndrome 0.0615 3.57 4,008 60 81 7,113 56.35
Klinefelter syndrome 0.0860 1.83 1,312 29 64 9,941 13.20
Fetal alcohol syndrome 0.1000 2.58 1,105 14 16 11,560 9.56
Cerebral palsy 0.1500 2.50 6,988 334 1 17,340 40.30
Down syndrome 0.1667 3.44 15,522 295 70 19,266 80.57
Tourette syndrome 0.5000 1.25 2,071 24 27 57,800 3.58
Autistic spectrum disorder 0.6500 2.90 16,071 1,468 18 75,140 21.39
Developmental dyscalculia 3.0000 1.56 229 15 14 346,800 0.07
Attention deficit hyperactivity disorder 5.0000 1.95 12,631 1,434 13 578,000 2.19
Intellectual disability
4 5.5000 2.75 17,721 497 19 635,800 2.79
Developmental dyslexia 6.0000 1.90 3,789 128 10 693,600 0.64
Developmental coordination disorder 6.5000 1.50 398 38 0 751,400 0.05
Specific language impairment 7.4000 2.15 1140 84 8 855,440 0.13
Speech sound disorder 10.0000 1.69 387 24 11 1,156,000 0.03
1Prevalence has been divided by two if reported for one sex only.
2Average N additional publications per 5 yr period.
3N publications in 25 yr per 100 affected cases in UK, based on population of 11.56 million children.
4Includes ‘learning disability’ if not specified as ‘specific’ (see text).
doi:10.1371/journal.pone.0015112.t003
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bands is logically independent from the publication index. This
measure revealed two clear outliers, autistic spectrum disorder,
and ADHD (see Table 3). Autism started from a high baseline,
with 1215 publications during 1985–1989, increasing 5-fold by
2005–2009. The increase for ADHD was even more dramatic,
from 356 publications in 1985–1989 to 6158 in 2005–2009. In
general, rate of increase in publications was positively correlated
with N publications in 1985–1989, rs=.35, N=35, p=.042, but a
high initial level of publications did not guarantee rapid growth.
For instance, Down syndrome started in 1985–1989 with 2121
publications, more than either ADHD or autism, but this had risen
only to 3474 by 2005–2009. It is noteworthy also that Lesch-
Nyhan syndrome, which had a remarkably high publication index,
showed a slight decrease in number of publications over a 25 year
period.
Table 4 shows data on NIH funding per condition by year, and
the slope of the function. There are striking parallels with the data
on publications. The Spearman correlation between the total N
publications from Table 3 and the total funding from Table 4 is
.883 (N=34, p,.0001) and the correlation between the slope
indicating increase in publications from 1985 to 2009, and the
slope of increase in NIH funding from 2000 to 2010 is .522
(N=34, p=.002). In a final analysis, the proportion of funding
from different NIH institutes was computed for the most common
neurodevelopmental disorders. These data are shown in Figure 2.
Discussion
Before discussing the results, it is important to note that the
range of conditions investigated is not comprehensive, and the
approach adopted here could be extended to include a wider
range of disorders. For instance, psychiatric conditions such as
antisocial behavior disorder and schizophrenia were not included
here, though a case can be made for treating them as
neurodevelopmental disorders [3]. Reliance on a textbook of
behavior phenotypes as a source book also meant that many
neurological disorders without clear genetic etiology, such as
congenital hypothyroidism or spina bifida, were also excluded.
It is also important to note that estimates of all of the main
variables in this analysis are imprecise. A frustrating feature of this
study was that is was hard to be confident that search terms
identified all relevant papers without including papers on other
conditions. Subsets of identified papers were scrutinised to ensure
that they reflected the intended content, but relevant articles would
be missed if they did not include the search terms in the title. For
Figure 1. Regression of log publication index on log severity, with 95% confidence interval shown with dotted lines. A constant of 4 is
added to log publication index to avoid negative numbers. Abbreviations: ADHD: attention deficit hyperactivity disorder; ASD: autism spectrum
disorder; CP: cerebral palsy; DCD: developmental co-ordination disorder; de Lange: Cornelia de Lange syndrome; FraX: fragile X; ID: intellectual
disability (shown in brackets to indicate that the publication index is overestimated); NF1: neurofibromatosis type 1; PKU: phenylketonuria; SLI:
specific language impairment; T. sclerosis: tuberous sclerosis; VCF: velocardiofacial syndrome.
doi:10.1371/journal.pone.0015112.g001
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of using search terms that would yield false positives. Thus, the
acronym SLI (used here for specific language impairment) is
associated with 16 meanings in Wikipedia, as well as referring to
genes in potatoes and worms. Attempts were made to restrict
searches to exclude such usages, but it is nevertheless likely that the
estimate for N publications is inflated by occasional errors. Another
condition that was difficult to search was XXX trisomy, because
XXX is used widely with a range of meanings. Conversely, the
estimate for velocardiofacial syndrome will be slightly deflated
because it was decided to exclude searches for papers with only the
acronym VCF in the title, given that this acronym refers to a host of
things other than velocardiofacial syndrome, and only a small
minority of publications including it in the title were relevant. As
noted above, identifying papers on intellectual disability was
particularly problematic, and estimates of research on this topic
are inflated because of the difficulty excluding articles on specific
learning disabilities. It is noteworthy that nevertheless the amount of
research on intellectual disability was below the level predicted from
severity and prevalence (see Figure 1).
The second key variable in the analysis is prevalence. Estimates
were taken from reputable published sources, but are bound to be
imprecise for very rare disorders. Furthermore, for some disorders,
especially those with multifactorial etiology, prevalence can vary
substantially depending on the severity cutoff used. For instance,
the prevalence of fetal alcohol syndrome disorder is estimated at 1
per 1000, but this condition is far less commonly identified in the
UK than in North America, where a milder phenotype of ‘fetal
alcohol spectrum disorder’ is recognised and estimated to be nine
times as common [7].
Table 4. Data from NIH RePort showing thousands of US dollars spent on projects relating to each disorder.
2000–2001 2002–2003 2004–2005 2006–2007 2008–2009
Anuual rate of increase
2000–2010
Developmental dyslexia 18,770 18,199 19,971 22,975 27,283 633
Developmental dyscalculia 0 0 400 369 1,574 151
Developmental coordination disorder 0 623 602 1,379 1,166 55
Speech sound disorder 858 876 501 964 1,116 8
Specific language impairment 16,279 16,219 15,389 18,133 28,611 780
Attention deficit hyperactivity disorder 274,500 346,039 314,232 365,207 532,800 13,042
Autistic spectrum disorder 95,114 171,707 360,765 355,458 851,270 50,978
Tourette syndrome 35,604 42,119 37,031 41,626 59,587 1,150
Angelman syndrome 13,039 12,103 11,156 12,392 21,246 594
Cerebral palsy 18,197 31,412 49,467 66,507 94,578 4,409
Cornelia de Lange syndrome 194 655 677 3,541 5,789 352
C r i d u c h a t s y n d r o m e 000002 5
Down syndrome 52,067 56,561 47,662 63,890 107,390 3,924
Duchenne muscular dystrophy 7,953 14,770 33,192 47,138 62,363 3,582
Fetal alcohol syndrome 40,955 51,783 69,504 83,447 105,668 3,905
Fragile X syndrome 28,316 44,054 54,187 67,584 125,661 5,532
Galactosaemia 2,802 5,737 4,398 4,416 6,060 371
Klinefelter syndrome 686 1,049 329 4,936 9,333 513
Lesch-Nyhan syndrome 1,030 1,803 2,049 1,960 6,601 240
Lowe syndrome 2,335 2,488 3,582 2,101 1,581 266
Marfan syndrome 3,426 4,825 5,701 9,847 20,455 872
Neurofibromatosis type 1 5,966 9,182 11,625 20,348 30,267 1,230
Noonan syndrome 0 1,138 9,099 10,615 8,650 546
Phenylketonuria 8,782 9,015 6,047 9,426 5,941 2151
Prader-Willi syndrome 14,284 15,512 17,924 17,042 24,802 620
Rett syndrome 5,194 10,235 14,980 24,650 48,575 2,995
Rubinstein-Taybi syndrome 1,023 2,766 2,304 2,648 6,032 225
Trisomy 18 0 0 578 282 0 0
Tuberous sclerosis 10,139 16,243 22,844 39,132 68,944 3,181
Turner syndrome 3,766 6,068 9,175 17,475 7,292 255
Velocardiofacial syndrome 5,042 7,229 6,850 5,632 3,895 2107
Williams syndrome 12,652 17,697 19,506 15,627 18,180 115
XXX 0 0 0 285 4,927 161
XYY 0 384 0 3,239 5,050 329
doi:10.1371/journal.pone.0015112.t004
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to the criteria from Table 2, averaging ratings across a range of
experts. All raters agreed that this was difficult to do for those
conditions with variable phenotype, such as tuberous sclerosis or
autistic spectrum disorder. For a condition such as intellectual
disability, severity will also depend on prevalence, with milder
forms being more common than more severe. Because it was in
general not possible to determine the severity of cases included in
specific studies, average estimates were taken, but results for
specific conditions need to take into account unreliability that is
inevitable when using these fuzzy estimates. Furthermore, the
severity scale was devised to assess how far the condition affected
educational attainment and adult independence, but did not take
into account physical symptoms that characterise some of the rarer
conditions. Thus, the majority of females with Turner syndrome
do not have significant intellectual impairment and live indepen-
dent adult lives, and hence this condition is rated as mild.
However, the syndrome involves cardiac problems and infertility,
which are not trivial symptoms.
Despite these limitations, the analysis gave a striking replication
of the findings on neurological conditions [1], namely that, when
prevalence is taken into account, the number of publications on
rare conditions is greatly in excess of that for common conditions.
At the extremes of the distribution considered here, between 1985
and 2009 there were 428 publications on Lesch-Nyhan syndrome,
which affects an estimated 57 children in the UK, compared with
340 publications on speech sound disorder, which affects over 1
million. However, these two extremes suggest a reason why this is
so: more research is done on more severe conditions. Speech
sound disorder can be marked and persistent, but it is usually a
relatively mild condition that is often transient and may have little
impact on a child’s social or educational prospects, whereas Lesch-
Nyhan syndrome has severe neurological and cognitive conse-
quences, including self-mutilation as a striking symptom, and is
associated with death from renal failure or hypotonia in childhood
or young adulthood. Overall, it was possible to show that a high
proportion of variance in number of publications could be
accounted for in terms of severity.
Furthermore, the amount of research on a given condition will
in part depend on the disciplines involved in investigating it. Given
the large number of identified publications, it was not possible to
classify the discipline of each one, but a rough index was obtained
to estimate the proportion of publications that involved genetic
investigations. Not surprisingly, these were more common for
single-gene disorders, most of which were rare. The amount of
genetic research on a disorder was also a significant independent
predictor of publication index.
There were some intriguing exceptions where severity failed to
predict research activity, which can be seen as outliers in Figure 1.
Within the conditions with presumed multifactorial etiology,
ADHD and autism spectrum disorder fell within the range of
predicted research, with Tourette syndrome slightly above
predicted levels. However, the publication indices for dyslexia,
dyscalculia, developmental coordination disorder and speech
sound disorder fell well below prediction. Dyslexia and SLI are
comparable to ADHD in prevalence and severity, yet the number
of publications for dyslexia was 4 times lower than for ADHD and
that for SLI was 16 times lower than ADHD. It is also interesting
to note that there were three times as many studies on
developmental dyslexia as on SLI, and nearly ten times as many
as on speech sound disorder, although these conditions are similar
in terms of rated severity and prevalence. It is perhaps relevant
that these latter two conditions posed particular problems when
searching for publications, because of the variable terminology
used to refer to cases, suggesting that diagnostic uncertainty might
be a factor leading to low research rates. This is a field where there
is considerable debate about how to diagnose and categorise cases,
whether there are disorders that are distinct from normal
variation, and where the same terminology that is used to refer
to a disorder is also used to refer to symptoms in other disorders.
Figure 2. Proportion of grant income from different NIH institutes for the most common neurodevelopmental disorders.
Abbreviations: NIMH: National Institute of Mental Health; NINDS: National Institute of Neurological Disorders and Stroke; NIDCD: National Institute on
Deafness and Other Communication DIsorders; NICHD: Eunice Kennedy Shriver National Institute of Child Health and Human Development.
doi:10.1371/journal.pone.0015112.g002
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of ICD-10 [8] and DSM-IV [9], few researchers adopted
definitions or nomenclature from the diagnostic manuals.
Another intriguing contrast is between Turner syndrome and
Klinefelter syndrome, both caused by sex chromosome aneuploi-
dies, and both affecting fertility. Table 3 indicates that there were
nearly two times as many publications on Turner syndrome as on
Klinefelter syndrome, even though Klinefelter syndrome is more
than three times as common. Here the discrepancy is likely to
relate to the ease of identification of affected individuals. The
prevalence rates for Klinefelter syndrome are derived from
prenatal and/or newborn surveys, but because the phenotype is
not striking, many affected individuals are not identified in
childhood. In contrast, the physical phenotype is far more obvious
in Turner syndrome. This kind of explanation could also account
for the dearth of studies on XYY and XXX trisomies; the majority
of affected individuals are not identified because the phenotype is
mild [10].
Even after taking into account severity and rates of genetic
research, prevalence still was a significant predictor, with higher
rates of publication for the rarer disorders. In considering reasons
for the higher publication ratios in rare vs. common diseases, Al-
Shahi et al.[1] noted that if the publication ratio for stroke were
equal to that of variant Creutzfeldt-Jakob disease, clinicians and
researchers interested in stroke would have had to read about 10
000 papers per week! One can turn this logic on its head and argue
that if rare disorders had a publication index comparable to that
for common disorders, there would be too few papers to give a
critical mass of evidence in the area. For instance, if we extrapolate
from the publication index for SLI (0.13 papers per 100 affected
children over the 25 year period), for rare conditions where the
national number of affected cases runs into hundreds rather than
thousands, there would be no effective research literature. For the
even rarer ‘orphan’ conditions with only a handful of affected
individuals, lack of research is recognised as a serious problem
[11]. The current analysis indicates that research activity on these
disorders would have to occur at a rate well in excess of that
predicted by extrapolation from more common disorders, in order
to have a critical mass of publications and build research capacity.
The data reported here also suggest a positive effect of critical
mass, insofar as the rate of growth in research on a disorder was
related to the number of publications recorded in the first time
interval, 1985–1989. This is compatible with the idea that a field
develops by skilled researchers training their students and
postdocs, who are likely to then study the same condition. If each
mentor trains several others, then growth will be exponential
rather than linear. Nevertheless, there were two conditions –
ADHD and autism spectrum disorder – where the growth in
research was unexpectedly high. For autism, there are two factors
that could be implicated: first, broadening of the diagnostic criteria
has led to a dramatic increase in diagnosis [12], and second,
research funding has been directed to this area, for instance, by the
Combating Autism Act passed in 2006 by the United States
Congress, which authorized nearly 1 billion dollars over five years
to combat autism and related disorders. For the more classic forms
of autism, both prevalence and severity are comparable to Down
syndrome, yet funding for autism is six times greater, and the slope
showing increase of NIH funding over time is dramatically higher
than for any other condition. It seems likely that government
initiatives play a large role in explaining the extraordinary rise of
publications in autism, though there are in addition several private
foundations that provide substantial funding for autism research.
The other condition showing a very high increase in
publications over time is ADHD, again with an associated high
level of NIH funding. ADHD is comparable in prevalence and
severity to SLI and dyslexia, and the proportion of genetic
research on ADHD is relatively low, yet it attracts 19 to 21 times
as much funding as these two conditions. Figure 2 suggests an
explanation in terms of the professional disciplines with primary
responsibility for these conditions. ADHD, like autism, is funded
through several NIH institutes, but primarily by NIMH,
suggesting most researchers in this field are psychiatrists. Dyslexia
is funded mainly through NICHD and is the domain of
psychologists, whereas SLI is funded mainly through NIDCD
and is investigated principally by speech-language pathologists.
This analysis suggests that inequities between professional
disciplines in access to research training and funding may do a
disservice to children who are affected by common yet under-
researched neurodevelopmental disorders.
In summary, it is misleading to focus only on prevalence when
comparing research activity for different conditions, as this
suggests a massive excess of research on rare disorders. If severity
is taken into account, the excess reduces considerably, although it
is still present. This may, however, have to do with critical mass of
research: there have to be proportionately more publications per
affected individual for rare than common disorders, to ensure
there is a body of work to build on. Nevertheless, even among
conditions of similar frequency and severity there are some
intriguing discrepancies in levels of research activity. It is suggested
that these may have to do with extent of involvement of genetic
researchers, specific initiatives in research funding, and lack of
research funding in some disciplines working with neurodevelop-
mental disorders.
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